194 related articles for article (PubMed ID: 16498500)
1. Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154.
Xu H; Zhang X; Mannon RB; Kirk AD
J Clin Invest; 2006 Mar; 116(3):769-74. PubMed ID: 16498500
[TBL] [Abstract][Full Text] [Related]
2. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
3. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
Wu Z; Wang Y; Gao F; Shen X; Zhai Y; Kupiec-Weglinski JW
J Immunol; 2008 Jul; 181(2):1096-102. PubMed ID: 18606661
[TBL] [Abstract][Full Text] [Related]
4. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
5. Critical role of OX40 in CD28 and CD154-independent rejection.
Demirci G; Amanullah F; Kewalaramani R; Yagita H; Strom TB; Sayegh MH; Li XC
J Immunol; 2004 Feb; 172(3):1691-8. PubMed ID: 14734751
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
[TBL] [Abstract][Full Text] [Related]
7. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation.
Charafeddine AH; Kim EJ; Maynard DM; Yi H; Weaver TA; Gunay-Aygun M; Russell M; Gahl WA; Kirk AD
Am J Transplant; 2012 Nov; 12(11):3143-51. PubMed ID: 22947105
[TBL] [Abstract][Full Text] [Related]
9. Contribution of CD40-CD154-mediated costimulation to an alloresponse in vivo.
Förster E; Krenger W; Joergensen J; Hof R; Geha RS; Holländer GA
Transplantation; 1999 May; 67(9):1284-7. PubMed ID: 10342324
[TBL] [Abstract][Full Text] [Related]
10. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
Zhai Y; Meng L; Gao F; Busuttil RW; Kupiec-Weglinski JW
J Immunol; 2002 Oct; 169(8):4667-73. PubMed ID: 12370407
[TBL] [Abstract][Full Text] [Related]
11. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R
J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743
[TBL] [Abstract][Full Text] [Related]
12. Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions.
Wang CY; Mazer SP; Minamoto K; Takuma S; Homma S; Yellin M; Chess L; Fard A; Kalled SL; Oz MC; Pinsky DJ
Circulation; 2002 Apr; 105(13):1609-14. PubMed ID: 11927531
[TBL] [Abstract][Full Text] [Related]
13. Disruption of CD154:CD40 blocks generation of allograft immunity without affecting APC activation.
Shepherd DM; Kerkvliet NI
J Immunol; 1999 Sep; 163(5):2470-7. PubMed ID: 10452982
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction.
Smiley ST; Csizmadia V; Gao W; Turka LA; Hancock WW
Transplantation; 2000 Aug; 70(3):415-9. PubMed ID: 10949181
[TBL] [Abstract][Full Text] [Related]
15. Role of CD40-CD154 pathway in the rejection of concordant and discordant xenogeneic islets.
Mai G; Bucher P; Morel P; Mei J; Bosco D; Andres A; Mathe Z; Wekerle T; Berney T; Bühler LH
Transplant Proc; 2005; 37(1):460-2. PubMed ID: 15808676
[TBL] [Abstract][Full Text] [Related]
16. New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs.
Sho M; Sandner SE; Najafian N; Salama AD; Dong V; Yamada A; Kishimoto K; Harada H; Schmitt I; Sayegh MH
Ann Surg; 2002 Nov; 236(5):667-75. PubMed ID: 12409674
[TBL] [Abstract][Full Text] [Related]
17. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
18. Impact of both donor and recipient strains on cardiac allograft survival after blockade of the CD40-CD154 costimulatory pathway.
van Maurik A; Wood KJ; Jones ND
Transplantation; 2002 Sep; 74(5):740-3. PubMed ID: 12352896
[TBL] [Abstract][Full Text] [Related]
19. Human platelets activate porcine endothelial cells through a CD154-dependent pathway.
Xu H; Arnaud F; Tadaki DK; Burkly LC; Harlan DM; Kirk AD
Transplantation; 2001 Dec; 72(11):1858-61. PubMed ID: 11740405
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade.
Wang Y; Dai H; Liu Z; Cheng X; Tellides G; Dai Z
Am J Transplant; 2006 Dec; 6(12):2851-60. PubMed ID: 17062001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
